Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Tsuboi

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Plastic and Reconstructive Surgery. Global Open|June 12, 2025
Using Condoms to Practice Venous End-to-side Anastomosis in MicrosurgeryKento Yamamoto, Zuzanna Granek, Kenji Tsuboi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 23, 2009
The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancerHidenobu Matsushita, Kenji Tsuboi, Ichiro Honda, et al.
Oncology Reports|October 25, 2008
Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasisKenji Tsuboi, Yasuhiro Kodera, Hayao Nakanishi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2016
[A Case of Portal Vein Thrombosis Occurring during CapeOX and Bevacizumab Combination Therapy for Liver Metastasis]Yasuo Uno, Kenji Tsuboi, Mitsuya Shimizu, et al.
Japanese Journal of Clinical Oncology|November 30, 2013
A randomized phase III trial exploring the prognostic value of extensive intraoperative peritoneal lavage in addition to standard treatment for resectable advanced gastric cancer: CCOG 1102 studyKazunari Misawa, Yoshinari Mochizuki, Norifumi Ohashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 22, 2009
[A case of advanced gastric cancer effectively treated with paclitaxel/S-1 as neoadjuvant chemotherapy]Hidenobu Matsushita, Ichiro Honda, Nobuyuki Kato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 23, 2010
[Elderly patient with recurrent rectal cancer successfully responded to modified FOLFOX6 chemotherapy with bevacizumab--a case report]Kenji Tsuboi, Yoshihisa Kawase, Nobuyuki Kato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2011
[Cetuximab-associated skin ulceration in patient with metastatic colorectal cancer: a case report]Kenji Tsuboi, Yoshihisa Kawase, Osamu Okochi, et al.
International Journal of Clinical Oncology|March 3, 2012
Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF studyTakao Takahashi, Yoshihisa Shibata, Yuichiro Tojima, et al.
Cancer Chemotherapy and Pharmacology|August 14, 2012
The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multicenter, single-arm, phase II trial (CCOG-0801)Goro Nakayama, Keisuke Uehara, Kiyoshi Ishigure, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Plastic and Reconstructive Surgery. Global Open|June 12, 2025
Using Condoms to Practice Venous End-to-side Anastomosis in MicrosurgeryKento Yamamoto, Zuzanna Granek, Kenji Tsuboi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 23, 2009
The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancerHidenobu Matsushita, Kenji Tsuboi, Ichiro Honda, et al.
Oncology Reports|October 25, 2008
Expression of CXCL12 and CXCR4 in pT3-stage gastric cancer does not correlate with peritoneal metastasisKenji Tsuboi, Yasuhiro Kodera, Hayao Nakanishi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 2016
[A Case of Portal Vein Thrombosis Occurring during CapeOX and Bevacizumab Combination Therapy for Liver Metastasis]Yasuo Uno, Kenji Tsuboi, Mitsuya Shimizu, et al.
Japanese Journal of Clinical Oncology|November 30, 2013
A randomized phase III trial exploring the prognostic value of extensive intraoperative peritoneal lavage in addition to standard treatment for resectable advanced gastric cancer: CCOG 1102 studyKazunari Misawa, Yoshinari Mochizuki, Norifumi Ohashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 22, 2009
[A case of advanced gastric cancer effectively treated with paclitaxel/S-1 as neoadjuvant chemotherapy]Hidenobu Matsushita, Ichiro Honda, Nobuyuki Kato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 23, 2010
[Elderly patient with recurrent rectal cancer successfully responded to modified FOLFOX6 chemotherapy with bevacizumab--a case report]Kenji Tsuboi, Yoshihisa Kawase, Nobuyuki Kato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 16, 2011
[Cetuximab-associated skin ulceration in patient with metastatic colorectal cancer: a case report]Kenji Tsuboi, Yoshihisa Kawase, Osamu Okochi, et al.
International Journal of Clinical Oncology|March 3, 2012
Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF studyTakao Takahashi, Yoshihisa Shibata, Yuichiro Tojima, et al.
Cancer Chemotherapy and Pharmacology|August 14, 2012
The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multicenter, single-arm, phase II trial (CCOG-0801)Goro Nakayama, Keisuke Uehara, Kiyoshi Ishigure, et al.
Pageof 2